Patents by Inventor Mitsuharu Hanada

Mitsuharu Hanada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9139658
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: December 23, 2010
    Date of Patent: September 22, 2015
    Assignee: SUMITOMO DAINIPPON PHARMA CO., LTD.
    Inventors: Toshihiro Noguchi, Akemi Baba, Mitsuharu Hanada
  • Publication number: 20110104160
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: December 23, 2010
    Publication date: May 5, 2011
    Applicant: Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Toshihiro NOGUCHI, Akemi Baba, Mitsuharu Hanada
  • Patent number: 7879327
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: June 11, 2007
    Date of Patent: February 1, 2011
    Assignee: Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Toshihiro Noguchi, Akemi Baba, Mitsuharu Hanada
  • Patent number: 7449181
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: July 26, 2001
    Date of Patent: November 11, 2008
    Assignee: Sumitomo Pharmaceuticals Company Limited
    Inventors: Toshihiro Noguchi, Akemi Baba, Mitsuharu Hanada
  • Publication number: 20080031881
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: June 11, 2007
    Publication date: February 7, 2008
    Applicant: Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Toshihiro NOGUCHI, Akemi Baba, Mitsuharu Hanada
  • Publication number: 20030157097
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: April 21, 2003
    Publication date: August 21, 2003
    Inventors: Toshihiro Noguchi, Akemi Baba, Mitsuharu Hanada